Donanemab is a monoclonal antibody that the U.S. Food and Drug Administration (FDA) approved on Tuesday with the goal of slowing the progression of early-stage symptomatic Alzheimer's disease.
© https://www.oann.com
Virtus (virtue, valor, excellence, courage, character, and worth)
Vincit (conquers, triumphs, and wins)